Siemens Healthineers has initiated the carve-out process for its in vitro diagnostics business, marking an important step toward establishing a standalone company that will operate under the name Olyrian (pronounced Oh-LEER-ee-an) Diagnostics. As Olyrian, the business will build on its century-long legacy with a clear purpose: to power human potential at the heart of care.
Siemens Healthineers has initiated the carve-out process for its in vitro diagnostics business, marking an important step toward establishing a standalone company that will operate under the name Olyrian (pronounced Oh-LEER-ee-an) Diagnostics. As Olyrian, the business will build on its century-long legacy with a clear purpose: to power human potential at the heart of care.